ASSOCIATION BETWEEN PERIODONTAL DISEASE AND CARDIOVASCULAR DISEASE
DOI:
https://doi.org/10.31984/oactiva.v8i1.682Keywords:
Periodontal diseases, cardiovascular diseases, periodontitisAbstract
Periodontal disease and systemic disorders continue to be a worldwide public health problem. In recent years, several studies have shown an association between periodontitis and cardiovascular diseases (CVD). Thus, this literature review aims to determine the association between periodontal disease and CVD. An exhaustive review of the literature in English was conducted to compile the publications of the last 12 years, utilizing the databases Wiley Online Library, PubMed, Google Scholar, Dialnet, PMC, BVS and Medline, using the following keywords: periodontal diseases, cardiovascular diseases and periodontitis. Only the most relevant publications were selected, obtaining a total of 56 articles. The association between periodontitis and CVD could be explained by chronic systemic inflammation and the influence of risk factors shared by both pathologies; nevertheless, future clinical studies are needed to establish a concrete relationship between the two diseases.
Key words: periodontal diseases, cardiovascular diseases, periodontitis.
Downloads
Download data is not yet available.
References
Referencias bibliográficas
1. Orlandi M, Graziani F, D’Aiuto F. Periodontal therapy and cardiovascular risk. Periodontology 2000. 2020; 83(1): 107-124. Disponible en: https://doi.org/10.1111/prd.12299
2. Sanz M, Marco del Castillo A, Jepsen S, Gonzalez J, D’Aiuto F, Bouchard P, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020; 47(3): 268-288. Disponible en: https://doi.org/10.1111/jcpe.13189
3. Cruz M, Cárdenas S, Moreno F, Moreno S. Enfermedad periodontal y enfermedad cardiovascular: una interacción extrema. Universitas Médica. 2015; 56(4): 491-508. Disponible en: https://www.redalyc.org/articulo.oa?id=231044020011
4. Pineda L, Toledo B, Veitia F. Enfermedad periodontal inflamatoria crónica y enfermedades cardiovasculares. Medicent Electrón. 2020; 24(2): 337-359. Disponible en: http://scielo.sld.cu/pdf/mdc/v24n2/1029-3043-mdc-24-02-337.pdf
5. Li C, Lv Z, Shi Z, Zhu Y, Wu Y, Li L, et al. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis (Review). Cochrane Database of Systematic Reviews. 2017; 11: 1-46. Disponible en: https://doi.org/10.1002/14651858.CD009197.pub3
6. Berlin Y, Febbraio M, Levin L. Association between apical periodontitis and cardiovascular diseases: a systematic review of the literature. International Endodontic Journal. 2017; 50(9): 847-859. Disponible en: https://doi.org/10.1111/iej.12710
7. Rodrigues T, de Figueiredo J, Figueiredo A, Lopes M, de Almeida A. Association between Chronic Apical Periodontitis and Coronary Artery Disease. J Endod. 2014; 40(2): 164-167. Disponible en: http://dx.doi.org/10.1016/j.joen.2013.10.026
8. Belstrøm D, Damgaard C, Nielsen C, Holmstrup P. Does a causal relation between cardiovascular disease and periodontitis exist? Microbes and Infection. 2012; 14(5): 411-418. Disponible en: https://doi.org/10.1016/j.micinf.2011.12.004
9. Bourgeois D, Inquimbert C, Ottolenghi L, Carrouel F. Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease – Is There Cause for Consideration? Microorganisms. 2019; 7(10): 1-17. Disponible en; https://doi.org/10.3390/microorganisms7100424
10. Sarmiento L, Velosa J, Arango D, Villegas M, Latorre C, Escobar F. Relación entre la presencia de enfermedad periodontal y el infarto agudo al miocardio por medio de la proteína C reactiva ultrasensible. Primera parte. Universitas Odontológica. 2015; 34(73): 21-30. Disponible en: https://doi.org/10.11144/Javeriana.uo34-73.rpep
11. Caton J, Armitage G, Berglundh T, Chapple I, Jepsen S, Kornman K, et al. A new classification scheme for periodontal and peri‐implant diseases and conditions – Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018; 45(20); S1–S8. Disponible en: https://doi.org/10.1111/jcpe.12935
12. Van T, Starr J. Unraveling the Link Between Periodontitis and Cardiovascular Disease. J Am Heart Assoc. 2013; 2(6): 1-2. Disponible en: https://doi.org/10.1161/JAHA.113.000657
13. Herrera D, Molina A, Buhlin K, Klinge B. Periodontal diseases and association with atherosclerotic disease. Periodontology 2000. 2020; 83(1): 66–89. Disponible en: https://doi.org/10.1111/prd.12302
14. Khumaedi A, Purnamasari D, Wijaya I, Soeroso Y. The relationship of diabetes, periodontitis and cardiovascular disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; 13(2): 1675-1678. Disponible en: https://doi.org/10.1016/j.dsx.2019.03.023
15. Cotti E, Mercuro G. Apical periodontitis and cardiovascular diseases: previous findings and ongoing research. International Endodontic Journal. 2015; 48(10): 926–932. Disponible en: https://doi.org/10.1111/iej.12506
16. Schulz S, Schlitt A, Hofmann B, Schaller H, Reichert S. Periodontal pathogens and their role in cardiovascular outcome. J Clin Periodontol. 2020; 47(2): 173–181. Disponible en: https://doi.org/10.1111/jcpe.13224
17. Martínez M, Camejo L, Sánchez R. Relación entre la enfermedad periodontal y la cardiopatía isquémica. Correo Científico Médico (CCM). 2019; 23(4): 2101-2121. Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3345/1473
18. Aarabi G, Zeller T, Seedorf H, Reissmann D, Heydecke G, Schaefer A, et al. Genetic Susceptibility Contributing to Periodontal and Cardiovascular Disease. Journal of Dental Research. 2017; 96(6): 610-617. Disponible en: https://doi.org/10.1177/0022034517699786
19. Albandar J, Susin C, Hughes F. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. J Periodontol. 2018; 89(1): S183–S203. Disponible en: https://doi.org/10.1002/JPER.16-0480
20. Herrera D, Retamal B, Alonso B, Feres M. Acute periodontal lesions (periodontal abscesses and necrotizing periodontal diseases) and endo‐periodontal lesions. J Clin Periodontol. 2018; 45(20): S78–S94. Disponible en: https://doi.org/10.1111/jcpe.12941
21. Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, et al. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int. J. Mol. Sci. 2019; 20(6); 2-14. Disponible en: https://doi.org/10.3390/ijms20061414
22. Yu Y-H, Chasman D, Buring J, Rose L, Ridker P. Cardiovascular risks associated with incident and prevalent periodontal disease. J Clin Periodontol 2014; 42(1): 21-28. Disponible en: https://doi.org/10.1111/jcpe.12335
23. Slocum C, Kramer C, Genco C. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis (Review). J Intern Med. 2016; 280(1): 114–128. Disponible en: https://doi.org/10.1111/joim.12476
24. Suzuki J-i, Imai Y, Aoki M, Fujita D, Aoyama N, Tada Y, et al. Periodontitis in Cardiovascular Disease Patients with or without Marfan Syndrome -A Possible Role of Prevotella intermedia-. PLoS ONE. 2014; 9(4): 1-4. Disponible en: https://doi.org/10.1371/journal.pone.0095521
25. Tonetti M, Van T and on behalf of working group 1 of the joint EFP/ AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol. 2013; 84(4): S24-S29. Disponible en: https://doi.org/10.1902/jop.2013.1340019
26. Falcao A, Bullón P. A review of the influence of periodontal treatment in systemic diseases. Periodontology 2000. 2019; 79(1): 117–128. Disponible en: https://doi.org/10.1111/prd.12249
27. Pizzicannella J, Diomede F, Merciaro I, Caputi S, Tartaro A, Guarnieri S, et al. Endothelial committed oral stem cells as modelling in the relationship between periodontal and cardiovascular disease. J Cell Physiol. 2018; 233(10): 6734–6747. Disponible en: https://doi.org/10.1002/jcp.26515
28. Vidal F, Cordovil I, Figueredo C, Fischer R. Non-surgical periodontal treatment reduces cardiovascular risk in refractory hypertensive patients: a pilot study. J Clin Periodontol. 2013; 40(7): 681-687. Disponible en: https://doi.org/10.1111/jcpe.12110
29. Qi J, Zihang Z, Zhang J, Park Y, Shrestha D, Jianling B, et al. Periodontal Antibodies and All-Cause and Cardiovascular Disease Mortality. Journal of Dental Research. 2019; 99(1): 51-59. Disponible en: https://doi.org/10.1177/0022034519884012
30. Delange N, Lindsay S, Lemus H, Finlayson T, Kelley S, Gottlieb R. Periodontal disease and its connection to systemic biomarkers of cardiovascular disease in young American Indian/Alaskan natives. J Periodontol. 2018; 89(2): 219–227. Disponible en: https://doi.org/10.1002/JPER.17-0319
31. Reichert S, Schulz S, Benten A, Lutze A, Seifert T, Schlitt M, et al. Periodontal conditions and incidence of new cardiovascular events among patients with coronary vascular disease. J Clin Periodontol. 2016; 43(11): 918-925. Disponible en: https://doi.org/10.1111/jcpe.12611
32. Schenkein H, Loos B. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol. 2013; 40(14): S51–S69. Disponible en: https://doi.org/10.1111/jcpe.12060
33. Montenegro M, Ribeiro I, Kampits C, Saffi M, Furtado M, Polanczyk C, et al. Randomized controlled trial of the effect of periodontal treatment on cardiovascular risk biomarkers in patients with stable coronary artery disease: Preliminary findings of 3 months. J Clin Periodontol. 2019; 46(3): 321–331. Disponible en: https://doi.org/10.1111/jcpe.13085
34. Sproston N, Ashworth J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Inmunol. 2018; 9: 754-765. Disponible en: https://doi.org/10.3389/fimmu.2018.00754
35. Isola G, Alibrandi A, Currò M, Matarese M, Ricca S, Matarese G, et al. Evaluation of salivary and serum asymmetric dimethylarginine (ADMA) levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. 2020; 91(8): 1076-1084. Disponible en: https://doi.org/10.1002/JPER.19-0446
36. Taha I, Naba A. Exploring the extracellular matrix in health and disease using proteomics. Essays Biochem. 2019; 63(3): 417-432. Disponible en: https://doi.org/10.1042/EBC20190001
37. Liljestrand J, Paju S, Buhlin K, Rutger G, Sarna S, Nieminen M, et al. Lipopolysaccharide, a possible molecular mediator between periodontitis and coronary artery disease. J Clin Periodontol. 2017; 44(8): 784-792. Disponible en: https://doi.org/10.1111/jcpe.12751
38. Schmitt A, Carra M, Boutouyrie P, Bouchard P. Periodontitis and arterial stiffness: a systematic review and meta-analysis. J Clin Periodontol. 2015; 42(11): 977–987. Disponible en: https://doi.org/10.1111/jcpe.12467
39. Romandini M, Lafori A, Romandini P, Baima G, Cordano M. Periodontitis and platelet count: A new potential link with cardiovascular and other systemic inflammatory diseases. J Clin Periodontol. 2018; 45(11): 1299–1310. Disponible en: https://doi.org/10.1111/jcpe.13004
40. Alshihayb T, Kaye E, Zhao Y, Leone C, Heaton B. The impact of periodontitis exposure misclassification bias from partial-mouth measurements on association with diabetes and cardiovascular disease. J Clin Periodontol. 2020; 47(12): 1457-1465. Disponible en: https://doi.org/10.1111/jcpe.13376
41. Holmlund A, Lampa E, Lind L. Oral health and cardiovascular disease risk in a cohort of periodontitis patients. Atherosclerosis. 2017; 262: 101-106. Disponible en: https://doi.org/10.1016/j.atherosclerosis.2017.05.009
42. Naderi S, Merchant A. The Association Between Periodontitis and Cardiovascular Disease: an Update. Curr Atheroscler Rep. 2020; 22(52): 1-5. Disponible en: https://doi.org/10.1007/s11883-020-00878-0
43. Stewart R, West M. Increasing Evidence for an Association Between Periodontitis and Cardiovascular Disease. Circulation. 2016; 133: 549-551. Disponible en: https://doi.org/10.1161/CIRCULATIONAHA.115.020869
44. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol. 2013; 40(14): S70–S84. Disponible en: https://doi.org/10.1111/jcpe.12062
45. Caúla A, Lira R, Barretto E, Guimaraes F. The effect of periodontal therapy on cardiovascular risk markers: a 6-month randomized clinical trial. J Clin Periodontol. 2014; 41(9): 875–882. Disponible en: https://doi.org/10.1111/jcpe.12290
46. McElveen W, Alway D. Ischemic Stroke and Transient Ischemic Attack – Acute Evaluation and Management. En: Alway D, editor. Stroke Essentials for Primary Care: A Practical Guide. 1a ed. Bradenton: Springer; 2009. p. 9-33. Disponible en: https://doi.org/10.1007/978-1-59745-433-9_2
47. Muñoz E, Suvan J, Buti J, Czesnikiewicz M, Barbosa A, Orlandi M, et al. Cardiovascular Research. 2020; 116(1): 28-39. Disponible en: https://doi.org/10.1093/cvr/cvz201
48. LaMonte M, Genco R, Hovey K, Wallace R, Freudenheim J, Michaud D, et al. History of Periodontitis Diagnosis and Edentulism as Predictors of Cardiovascular Disease, Stroke, and Mortality in Postmenopausal Women. J Am Heart Assoc. 2017; 6(4): 1-11. Disponible en: https://doi.org/10.1161/JAHA.116.004518
49. Holmlund A, Lampa E, Lind L. Poor Response to Periodontal Treatment May Predict Future Cardiovascular Disease. Journal of Dental Research. 2017; 96(7): 768-773. Disponible en: https://doi.org/10.1177/0022034517701901
50. Cotti E, Arrica M, Di Lenarda A, Serri S, Bassaero P, Padeletti L, et al. The perioperative dental screening and management of patients undergoing cardiothoracic, vascular surgery and other cardiovascular invasive procedures: A systematic review. European Journal of Preventive Cardiology. 2017; 24(4): 409-425. Disponible en: https://doi.org/10.1177/2047487316682348
51. Ferreira J, Girerd N, Bozec E, Machu J, Boivin J, London G, et al. Intima–Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population‐Based Cohort (STANISLAS Cohort Study). J Am Heart Assoc. 2016; 5(6). Disponible en: https://doi.org/10.1161/JAHA.116.003529
52. Liu W, Cao Y, Dong L, Zhu Y, Wu Y, Lv Z. Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis (Review). Cochrane Database of Systematic Reviews. 2019; 12: 1-45. Disponible en: https://doi.org/10.1002/14651858.CD009197.pub4
53. Garde S, Akhter R, Anh M, Chow C, Eberhard J. Periodontal Therapy for Improving Lipid Profiles in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2019; 20(15): 1-13. Disponible en: https://doi.org/10.3390/ijms20153826
54. Patriota Y, Chaves L, Gocke E, Severino P, Soares M, Soares J, et al. Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems. Appl. Nano. 2021; 2(2): 98–117. Disponible en: https://doi.org/10.3390/applnano2020009
55. Muñoz N, Fuentes C, Castillo A, González L, Vecchiola A, Fardella C, et al. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension. Int. J. Mol. Sci. 2016; 17(7); 1-17. Disponible en: https://doi.org/10.3390/ijms17070797
56. Beck J, Papapanou P, Philips K, Offenbacher S. Periodontal Medicine: 100 Years of Progress. Journal of Dental Research. 2019; 98(10): 1053–1062. Disponible en: https://doi.org/10.1177/0022034519846113
1. Orlandi M, Graziani F, D’Aiuto F. Periodontal therapy and cardiovascular risk. Periodontology 2000. 2020; 83(1): 107-124. Disponible en: https://doi.org/10.1111/prd.12299
2. Sanz M, Marco del Castillo A, Jepsen S, Gonzalez J, D’Aiuto F, Bouchard P, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020; 47(3): 268-288. Disponible en: https://doi.org/10.1111/jcpe.13189
3. Cruz M, Cárdenas S, Moreno F, Moreno S. Enfermedad periodontal y enfermedad cardiovascular: una interacción extrema. Universitas Médica. 2015; 56(4): 491-508. Disponible en: https://www.redalyc.org/articulo.oa?id=231044020011
4. Pineda L, Toledo B, Veitia F. Enfermedad periodontal inflamatoria crónica y enfermedades cardiovasculares. Medicent Electrón. 2020; 24(2): 337-359. Disponible en: http://scielo.sld.cu/pdf/mdc/v24n2/1029-3043-mdc-24-02-337.pdf
5. Li C, Lv Z, Shi Z, Zhu Y, Wu Y, Li L, et al. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis (Review). Cochrane Database of Systematic Reviews. 2017; 11: 1-46. Disponible en: https://doi.org/10.1002/14651858.CD009197.pub3
6. Berlin Y, Febbraio M, Levin L. Association between apical periodontitis and cardiovascular diseases: a systematic review of the literature. International Endodontic Journal. 2017; 50(9): 847-859. Disponible en: https://doi.org/10.1111/iej.12710
7. Rodrigues T, de Figueiredo J, Figueiredo A, Lopes M, de Almeida A. Association between Chronic Apical Periodontitis and Coronary Artery Disease. J Endod. 2014; 40(2): 164-167. Disponible en: http://dx.doi.org/10.1016/j.joen.2013.10.026
8. Belstrøm D, Damgaard C, Nielsen C, Holmstrup P. Does a causal relation between cardiovascular disease and periodontitis exist? Microbes and Infection. 2012; 14(5): 411-418. Disponible en: https://doi.org/10.1016/j.micinf.2011.12.004
9. Bourgeois D, Inquimbert C, Ottolenghi L, Carrouel F. Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease – Is There Cause for Consideration? Microorganisms. 2019; 7(10): 1-17. Disponible en; https://doi.org/10.3390/microorganisms7100424
10. Sarmiento L, Velosa J, Arango D, Villegas M, Latorre C, Escobar F. Relación entre la presencia de enfermedad periodontal y el infarto agudo al miocardio por medio de la proteína C reactiva ultrasensible. Primera parte. Universitas Odontológica. 2015; 34(73): 21-30. Disponible en: https://doi.org/10.11144/Javeriana.uo34-73.rpep
11. Caton J, Armitage G, Berglundh T, Chapple I, Jepsen S, Kornman K, et al. A new classification scheme for periodontal and peri‐implant diseases and conditions – Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018; 45(20); S1–S8. Disponible en: https://doi.org/10.1111/jcpe.12935
12. Van T, Starr J. Unraveling the Link Between Periodontitis and Cardiovascular Disease. J Am Heart Assoc. 2013; 2(6): 1-2. Disponible en: https://doi.org/10.1161/JAHA.113.000657
13. Herrera D, Molina A, Buhlin K, Klinge B. Periodontal diseases and association with atherosclerotic disease. Periodontology 2000. 2020; 83(1): 66–89. Disponible en: https://doi.org/10.1111/prd.12302
14. Khumaedi A, Purnamasari D, Wijaya I, Soeroso Y. The relationship of diabetes, periodontitis and cardiovascular disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; 13(2): 1675-1678. Disponible en: https://doi.org/10.1016/j.dsx.2019.03.023
15. Cotti E, Mercuro G. Apical periodontitis and cardiovascular diseases: previous findings and ongoing research. International Endodontic Journal. 2015; 48(10): 926–932. Disponible en: https://doi.org/10.1111/iej.12506
16. Schulz S, Schlitt A, Hofmann B, Schaller H, Reichert S. Periodontal pathogens and their role in cardiovascular outcome. J Clin Periodontol. 2020; 47(2): 173–181. Disponible en: https://doi.org/10.1111/jcpe.13224
17. Martínez M, Camejo L, Sánchez R. Relación entre la enfermedad periodontal y la cardiopatía isquémica. Correo Científico Médico (CCM). 2019; 23(4): 2101-2121. Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3345/1473
18. Aarabi G, Zeller T, Seedorf H, Reissmann D, Heydecke G, Schaefer A, et al. Genetic Susceptibility Contributing to Periodontal and Cardiovascular Disease. Journal of Dental Research. 2017; 96(6): 610-617. Disponible en: https://doi.org/10.1177/0022034517699786
19. Albandar J, Susin C, Hughes F. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. J Periodontol. 2018; 89(1): S183–S203. Disponible en: https://doi.org/10.1002/JPER.16-0480
20. Herrera D, Retamal B, Alonso B, Feres M. Acute periodontal lesions (periodontal abscesses and necrotizing periodontal diseases) and endo‐periodontal lesions. J Clin Periodontol. 2018; 45(20): S78–S94. Disponible en: https://doi.org/10.1111/jcpe.12941
21. Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, et al. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int. J. Mol. Sci. 2019; 20(6); 2-14. Disponible en: https://doi.org/10.3390/ijms20061414
22. Yu Y-H, Chasman D, Buring J, Rose L, Ridker P. Cardiovascular risks associated with incident and prevalent periodontal disease. J Clin Periodontol 2014; 42(1): 21-28. Disponible en: https://doi.org/10.1111/jcpe.12335
23. Slocum C, Kramer C, Genco C. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis (Review). J Intern Med. 2016; 280(1): 114–128. Disponible en: https://doi.org/10.1111/joim.12476
24. Suzuki J-i, Imai Y, Aoki M, Fujita D, Aoyama N, Tada Y, et al. Periodontitis in Cardiovascular Disease Patients with or without Marfan Syndrome -A Possible Role of Prevotella intermedia-. PLoS ONE. 2014; 9(4): 1-4. Disponible en: https://doi.org/10.1371/journal.pone.0095521
25. Tonetti M, Van T and on behalf of working group 1 of the joint EFP/ AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol. 2013; 84(4): S24-S29. Disponible en: https://doi.org/10.1902/jop.2013.1340019
26. Falcao A, Bullón P. A review of the influence of periodontal treatment in systemic diseases. Periodontology 2000. 2019; 79(1): 117–128. Disponible en: https://doi.org/10.1111/prd.12249
27. Pizzicannella J, Diomede F, Merciaro I, Caputi S, Tartaro A, Guarnieri S, et al. Endothelial committed oral stem cells as modelling in the relationship between periodontal and cardiovascular disease. J Cell Physiol. 2018; 233(10): 6734–6747. Disponible en: https://doi.org/10.1002/jcp.26515
28. Vidal F, Cordovil I, Figueredo C, Fischer R. Non-surgical periodontal treatment reduces cardiovascular risk in refractory hypertensive patients: a pilot study. J Clin Periodontol. 2013; 40(7): 681-687. Disponible en: https://doi.org/10.1111/jcpe.12110
29. Qi J, Zihang Z, Zhang J, Park Y, Shrestha D, Jianling B, et al. Periodontal Antibodies and All-Cause and Cardiovascular Disease Mortality. Journal of Dental Research. 2019; 99(1): 51-59. Disponible en: https://doi.org/10.1177/0022034519884012
30. Delange N, Lindsay S, Lemus H, Finlayson T, Kelley S, Gottlieb R. Periodontal disease and its connection to systemic biomarkers of cardiovascular disease in young American Indian/Alaskan natives. J Periodontol. 2018; 89(2): 219–227. Disponible en: https://doi.org/10.1002/JPER.17-0319
31. Reichert S, Schulz S, Benten A, Lutze A, Seifert T, Schlitt M, et al. Periodontal conditions and incidence of new cardiovascular events among patients with coronary vascular disease. J Clin Periodontol. 2016; 43(11): 918-925. Disponible en: https://doi.org/10.1111/jcpe.12611
32. Schenkein H, Loos B. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol. 2013; 40(14): S51–S69. Disponible en: https://doi.org/10.1111/jcpe.12060
33. Montenegro M, Ribeiro I, Kampits C, Saffi M, Furtado M, Polanczyk C, et al. Randomized controlled trial of the effect of periodontal treatment on cardiovascular risk biomarkers in patients with stable coronary artery disease: Preliminary findings of 3 months. J Clin Periodontol. 2019; 46(3): 321–331. Disponible en: https://doi.org/10.1111/jcpe.13085
34. Sproston N, Ashworth J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Inmunol. 2018; 9: 754-765. Disponible en: https://doi.org/10.3389/fimmu.2018.00754
35. Isola G, Alibrandi A, Currò M, Matarese M, Ricca S, Matarese G, et al. Evaluation of salivary and serum asymmetric dimethylarginine (ADMA) levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. 2020; 91(8): 1076-1084. Disponible en: https://doi.org/10.1002/JPER.19-0446
36. Taha I, Naba A. Exploring the extracellular matrix in health and disease using proteomics. Essays Biochem. 2019; 63(3): 417-432. Disponible en: https://doi.org/10.1042/EBC20190001
37. Liljestrand J, Paju S, Buhlin K, Rutger G, Sarna S, Nieminen M, et al. Lipopolysaccharide, a possible molecular mediator between periodontitis and coronary artery disease. J Clin Periodontol. 2017; 44(8): 784-792. Disponible en: https://doi.org/10.1111/jcpe.12751
38. Schmitt A, Carra M, Boutouyrie P, Bouchard P. Periodontitis and arterial stiffness: a systematic review and meta-analysis. J Clin Periodontol. 2015; 42(11): 977–987. Disponible en: https://doi.org/10.1111/jcpe.12467
39. Romandini M, Lafori A, Romandini P, Baima G, Cordano M. Periodontitis and platelet count: A new potential link with cardiovascular and other systemic inflammatory diseases. J Clin Periodontol. 2018; 45(11): 1299–1310. Disponible en: https://doi.org/10.1111/jcpe.13004
40. Alshihayb T, Kaye E, Zhao Y, Leone C, Heaton B. The impact of periodontitis exposure misclassification bias from partial-mouth measurements on association with diabetes and cardiovascular disease. J Clin Periodontol. 2020; 47(12): 1457-1465. Disponible en: https://doi.org/10.1111/jcpe.13376
41. Holmlund A, Lampa E, Lind L. Oral health and cardiovascular disease risk in a cohort of periodontitis patients. Atherosclerosis. 2017; 262: 101-106. Disponible en: https://doi.org/10.1016/j.atherosclerosis.2017.05.009
42. Naderi S, Merchant A. The Association Between Periodontitis and Cardiovascular Disease: an Update. Curr Atheroscler Rep. 2020; 22(52): 1-5. Disponible en: https://doi.org/10.1007/s11883-020-00878-0
43. Stewart R, West M. Increasing Evidence for an Association Between Periodontitis and Cardiovascular Disease. Circulation. 2016; 133: 549-551. Disponible en: https://doi.org/10.1161/CIRCULATIONAHA.115.020869
44. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol. 2013; 40(14): S70–S84. Disponible en: https://doi.org/10.1111/jcpe.12062
45. Caúla A, Lira R, Barretto E, Guimaraes F. The effect of periodontal therapy on cardiovascular risk markers: a 6-month randomized clinical trial. J Clin Periodontol. 2014; 41(9): 875–882. Disponible en: https://doi.org/10.1111/jcpe.12290
46. McElveen W, Alway D. Ischemic Stroke and Transient Ischemic Attack – Acute Evaluation and Management. En: Alway D, editor. Stroke Essentials for Primary Care: A Practical Guide. 1a ed. Bradenton: Springer; 2009. p. 9-33. Disponible en: https://doi.org/10.1007/978-1-59745-433-9_2
47. Muñoz E, Suvan J, Buti J, Czesnikiewicz M, Barbosa A, Orlandi M, et al. Cardiovascular Research. 2020; 116(1): 28-39. Disponible en: https://doi.org/10.1093/cvr/cvz201
48. LaMonte M, Genco R, Hovey K, Wallace R, Freudenheim J, Michaud D, et al. History of Periodontitis Diagnosis and Edentulism as Predictors of Cardiovascular Disease, Stroke, and Mortality in Postmenopausal Women. J Am Heart Assoc. 2017; 6(4): 1-11. Disponible en: https://doi.org/10.1161/JAHA.116.004518
49. Holmlund A, Lampa E, Lind L. Poor Response to Periodontal Treatment May Predict Future Cardiovascular Disease. Journal of Dental Research. 2017; 96(7): 768-773. Disponible en: https://doi.org/10.1177/0022034517701901
50. Cotti E, Arrica M, Di Lenarda A, Serri S, Bassaero P, Padeletti L, et al. The perioperative dental screening and management of patients undergoing cardiothoracic, vascular surgery and other cardiovascular invasive procedures: A systematic review. European Journal of Preventive Cardiology. 2017; 24(4): 409-425. Disponible en: https://doi.org/10.1177/2047487316682348
51. Ferreira J, Girerd N, Bozec E, Machu J, Boivin J, London G, et al. Intima–Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population‐Based Cohort (STANISLAS Cohort Study). J Am Heart Assoc. 2016; 5(6). Disponible en: https://doi.org/10.1161/JAHA.116.003529
52. Liu W, Cao Y, Dong L, Zhu Y, Wu Y, Lv Z. Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis (Review). Cochrane Database of Systematic Reviews. 2019; 12: 1-45. Disponible en: https://doi.org/10.1002/14651858.CD009197.pub4
53. Garde S, Akhter R, Anh M, Chow C, Eberhard J. Periodontal Therapy for Improving Lipid Profiles in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2019; 20(15): 1-13. Disponible en: https://doi.org/10.3390/ijms20153826
54. Patriota Y, Chaves L, Gocke E, Severino P, Soares M, Soares J, et al. Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems. Appl. Nano. 2021; 2(2): 98–117. Disponible en: https://doi.org/10.3390/applnano2020009
55. Muñoz N, Fuentes C, Castillo A, González L, Vecchiola A, Fardella C, et al. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension. Int. J. Mol. Sci. 2016; 17(7); 1-17. Disponible en: https://doi.org/10.3390/ijms17070797
56. Beck J, Papapanou P, Philips K, Offenbacher S. Periodontal Medicine: 100 Years of Progress. Journal of Dental Research. 2019; 98(10): 1053–1062. Disponible en: https://doi.org/10.1177/0022034519846113
Published
2023-03-10
ESTADISTICAS
- Abstract 1714
- DESCARGAR EN PDF (Español (España)) 1048
- HTML (Español (España)) 168
How to Cite
Gutiérrez Solano, M. P., & Centeno Dávila, M. del C. (2023). ASSOCIATION BETWEEN PERIODONTAL DISEASE AND CARDIOVASCULAR DISEASE. Odontología Activa Revista Científica, 8(1), 43–56. https://doi.org/10.31984/oactiva.v8i1.682
Issue
Section
Bibliographic revision articles
License
Copyright (c) 2023 Odontología Activa Revista Científica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Se autoriza la reproducción total y parcial, y la citación del material que aparece en la revista, siempre y cuando se indique de manera explícita: nombre de la revista, nombre del autor(es), año, volumen, número y páginas del artículo fuente. Las ideas y afirmaciones consignadas por los autores están bajo su responsabilidad y no interpretan necesariamente las opiniones y políticas del Consejo Editorial de la Revista OActiva ni de la Universidad Católica de Cuenca.
La Revista OActiva utiliza la Licencia Creative Commons de Reconocimeinto-NoComercial-CompartirIgual 4.0, que es la siguiente: CC BY-NC-SA 4.0 Internacional.
